CASE PRESENTATION DR NADIA SHAFIQUE. CASE SUMMARY  38 yrs old female GULSHAN diagnosed case of HCV related DCLD (child class C) CTP score 11presented.

Slides:



Advertisements
Similar presentations
Management of ascites in cirrhosis
Advertisements

Clinical Course of Untreated BA Phoebe part. Clinical Course of Untreated BA Most present within four to six weeks of conjugated jaundice and acholic.
CIRRHOSIS. Use of nonspecific has been studied extensively in randomized, controlled trials of the primary prophylaxis of variceal bleeding. β-adrenergic.
 Brian Torski, DO, Internal Medicine PGY-1.  Overview of Hepatorenal Syndrome o Pathophysiology o Diagnosis o Classification o Prevention and Treatment.
Chronic Liver Disease Simon Lynes. Definition Progressive destruction and regeneration of the liver parenchyma leading to fibrosis and cirrhosis.
Acute Upper Gastrointestinal Hemorrhage “Surgical Perspective”
Teaching Liver cirrhosis with varices. Discussion  Approximately half of patients with cirrhosis have esophageal varices  One-third of all patients.
MAZEN HASSANAIN PORTAL HYPERTENSION. CAUSES Cirrhosis Non-cirrhosis.
Management of ascites in patients with cirrhosis Treviso 4 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
For final year medical students 2014 Dr Rosalind Pool GPST1
Treatment of chronic liver disease. Treatment Cause ( Etiology) Cause ( Etiology) Complication Complication.
CDI Education Cirrhosis 4/17/2017.
Complications of Liver Cirrhosis Ayman Abdo MD, AmBIM, FRCPC.
Liver pathology: CIRRHOSIS
- Definition: - Causes: 1.Liver cirrhosis (Com.). 2.Extra hepatic portal v. occlusion. 3.Intra hepatic veno occlusive Dis. 4.Occlusion of hepatic vein.
PORTAL HYPERTENSION & CHRONIC LIVER DISEASE SEAN CHEN ST GEORGE HEPATOBILIARY & PANCREATIC WORKSHOP 31/05/2014.
Cirrhosis of Liver: Continuation Nursing 2015 Part two 22 to 42slides.
NYU Medical Grand Rounds Clinical Vignette Jeffrey Mayne, MD Third Year Resident Internal Medicine 1/17/2012 U NITED S TATES D EPARTMENT OF V ETERANS A.
IV CURSO PARA RESIDENTES DE LA AEEH DIAGNÓSTICO Y TRATAMIENTO DE LAS ENFERMEDADES HEPÁTICAS Barcelona, de Octubre de 2013 ASCITIS Y SINDROME HEPATORRENAL.
Approach - Management of ascites in cirrhotic patients Dr. Khaled sheha.
TIPS on Portal Hypertension for Surgeons John R. Potts, III, M.D., F.A.C.S. Program Director in Surgery Assistant Dean Graduate Medical Education University.
Hepatorenal Syndrome Dr Allister J Grant Leicester Liver Unit
Creatinine (mg/dL) MonthsWeeks Therapeutic paracentesis Cefotaxime Type-2 HRSType-1 HRS Encephalopathy Jaundice CLINICAL TYPES.
Portal Hypertension portal venous pressure > 5 mmHg
Transjugular Intrahepatic Portosystemic Shunt (TIPS) Presented by R2 吳佳展 2002/10/01.
Transhepatic venous cardiac catheterization
Chronic Liver Disease. Burden Markedly decreased life expectancy 12th leading cause of death in US 25,000 deaths annually in US High morbidity and mortality.
Gastroenterology and Hepatology Board Review II December 7, 2012.
Cirrhosis 18 November 2009 Thomas C Sodeman MD Associate Professor of Medicine Chief, Division of Gastroenterology.
INTERFERENCE TO NUTRITIONAL NEEDS DUE TO DEGENERATION AND INFLAMMATION Cirrhosis and Hepatitis.
Transjugular Intrahepatic Portosytemic Shunt Kevin A. Smith, MD Interventional Radiologist Roper Radiologists, PA.
Portal Hypertension Mazen Hassanain.
A 57-year-old man presents with fatigue for several months. He underwent a blood transfusion with several units in 1982 after car accident. Physical examination.
Complications of liver cirrhosis
Interventional Radiology Radiology has provoked from providing purely diagnostic information to therapy, offering effective alternatives in the Rx.
Complications of Liver Cirrhosis
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Management of patients with cirrhosis and refractory ascites Treviso 4 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of.
TIPS Made Easy: A Procedure Review
From Hemobilia to Hematochezia A 49-year-old woman transferred from an outside hospital because of severe hematochezia with a drop in hemoglobin from 14.
Medical Grand Round - Disease review
Ascites 소화기내과 F1 김경엽.  Ascites: pathologic accumulation of fluid in the peritoneal cavity Causes of ascitesPercentage Cirrhosis81 % Cancer10 % Heart.
Definition  Is a chronic disease characterized by scaring and necrotic tissue replaced by fibrotic tissue. Resulting in hepatic insufficiency and portal.
Dominique Valla, Richard Moreau, and Didier Lebrec
Short-term effects of combination of satavaptan, a selective vasopressin V 2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without.
Chronic liver disease Multiple causes, common manifestation.
INTERNAL MEDICINE BENJAMIN YIP 4/13/16 Mini Lecture: Hepatorenal Syndrome.
Transjugular Intrahepatic Portosystemic Shunt (TIPS) R4 박철기.
Approach to Ascites Updated by Daniel Kim, 06/2017.
Liver Disease tutoring Part 2
Portal Hypertension.
AN INTERESTING CAUSE FOR CHRONIC LIVER DISEASE
Portal Hypertension.
Portal Hypertension Dr. HAMID HINDI.
GASTROENTEROLOGY 2009;137:892–901 R2. 정 회 훈.
ASCITES By Dr WAQAR MBBS, MRCP Asst. Professor Maarefa College.
Successful TACE for HCC
Managing Complications of Cirrhosis
Orthotopic liver transplant, recurrent non-alcoholic steatohepatitis
Comorbidity NASH/HCV and HCC
Multiple factors can predispose to decompensation in a patient with cirrhosis. Risk factors for decompensation include: Bleeding Infection Alcohol.
Care of Patients with Liver Problems
Vandana Khungar, Sammy Saab  Clinical Gastroenterology and Hepatology 
Andres Cardenas, Pere Ginès  Journal of Hepatology 
Internal medicine L-4 Liver cirrhosis & portal hypertension
Douglas A. Simonetto, MD, Mengfei Liu, MD, Patrick S. Kamath, MD 
CLINICAL PRACTICE GUIDELINES FOR MANAGEMENT OF ASCITES, SBP AND HRS
LIVER CIRRHOSIS IN PSC: DIAGNOSIS AND MANAGEMENT
Hepatic Hydrothorax.
Presentation transcript:

CASE PRESENTATION DR NADIA SHAFIQUE

CASE SUMMARY  38 yrs old female GULSHAN diagnosed case of HCV related DCLD (child class C) CTP score 11presented with c/o increasing abdominal distention for 3 months, off and on gum bleeding and vomiting for 3 days.  On examination she was pallor, jaundiced, bilateral pitting pedal oedema and marked ascities. Rest of the clinical examination was unremarkable.

LABORATORY TEST  Hb 9.6,TLC 10900,PLT count  PT 26/13 sec,APTT 51/3417sec  S.bili 2.7mg/dl,ALT 30U/l, Alk Phos 256 U/L  Urea 73mg/dl, creatinine 2.5mg/dl  Ascitic fluid analysis showed TLC of 250/cmm, neutrophils 88% and lymphocytes 12%, protein 1.0 g/dl  Endoscopy showed F2 oesophageal varicies and moderate portal gastropathy.

TREATMENT  She was managed with dietary restriction of sodium to and water restriction of 1.5litres/day.  Lactulose, spironolactone (400mg/dl ) furosimide ( 120mg/dl),omeprazole,propranolol for 8 weeks.  FFPs were transfused and large volume therapeutic paracentesis was done five times (upto 10 litres fluid tapped at intervals)under cover of haemaccel.cannot afford i/v albumin due to affordability reason.

OUTCOME  She did not respond to dietry restriction of sodium,water and maximum dose of diuretics.  Labelled as having refractory ascities.

REFRACTORY ASCITIES  Refractory ascites defined as failure to respond to sodium restriction of 50 mmol/d, a combination of spironolactone 400 mmol/d and frusemide 160 mg/d or bumetanide 4 mg/d, evidenced by weight loss of less than 200 g/d and urine sodium below 50 mmol/d over 4 days of intense diuretic therapy, or recurrance of ascites within 4 weeks of medical therapy of paracentesis which cannot be prevented by medical therapy.

TREATMENT OPTIONS  Salt (85mmol/day) and water restriction(1.5 litres/day)  Diuretics  Large volume paracentesis  TIPSS  Portovenous shunt  Liver transplant

TRANSJUGULAR INTRAHEPATIC PORTO SYSTEMIC SHUNT  Transjugular intrahepatic portosystemic shunts (TIPS) are an effective method for reducing portal vein pressure.  TIPS creation is a percutaneous method of reducing portal vein pressure wherein a decompressive channel is created between a hepatic vein and an intrahepatic branch of the portal vein.

 Creating a TIPS involves several steps:  Catheterization of the hepatic veins and hepatic venography  Passage of a long curved transjugular needle from the chosen hepatic vein through the liver parenchyma into an intrahepatic branch of the portal vein.  Direct measurement of the systemic and portal vein pressures through the transjugular access.  Balloon dilation of the tract between the hepatic and portal veins.  Deployment of a metallic stent within the tract to maintain it against the recoil of the surrounding liver parenchyma.  Angiographic and hemodynamic assessment of the resultant pressure reduction.  Serial dilation of the stent until satisfactory pressure levels have been reached.  Variceal embolization when indicated

INDICATIONS  Uncontrollable variceal hemorrhage.  Recurrent variceal hemorrhage despite endoscopic therapy.  Portal hypertensive gastropathy.  Refractory ascites.  Hepatic hydrothorax.  Budd-Chiari syndrome

CONTRAINDICATIONS  Elevated right or left heart pressures.  Heart failure or cardiac valvular insufficiency.  Rapidly progressive liver failure.  Severe or uncontrolled hepatic encephalopathy.  Uncontrolled systemic infection or sepsis.  Unrelieved biliary obstruction.  Polycystic liver disease.  Extensive primary or metastatic hepatic malignancy.  Severe, uncorrectable coagulopathy

 Comparison of paracentesis and transjugular intrahepatic porto systemic shunting in patients with ascities.( june 8,2000 NEJM)  The probability of survival without liver transplantation was 69 percent at one year and 58 percent at two years in the shunt group, as compared with 52 percent and 32 percent in the paracentesis group  At three months, 61 percent of the patients in the shunt group and 18 percent of those in the paracentesis group had no ascites. The frequency of hepatic encephalopathy was similar in the two groups.

COMPARISON OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT WITH LARGE VOLUME PARACENTESIS

COMPLICATIONS  Transient or permanent contrast induced renal failure  Fever  Hepatic infarction  Entry site hematoma  Muscle stiffnes  Occlusion of stent  Hepatic artery puncture  Encephalopathy  Heart arrythmias  Sub capsular hematoma  Abdominal bleeding  Death(very rare)

THANKYOU